House Bill 4409 would create a new act, the Drug Manufacturer Data Reporting Act, which would require drug manufacturers to disclose certain information on costs and pricing to the Department of Insurance and Financial Services (DIFS) on an annual basis. The reports and information would be exempt from disclosure under the Freedom of Information Act (FOIA). DIFS could promulgate rules to implement the act